Safety and efficacy of the novel sirolimus‐eluting bioresorbable scaffold for the treatment of de novo coronary artery disease: One‐year results from a prospective patient‐level pooled analysis of NeoVas trials-Reference-Cited by-同舟云学术

Safety and efficacy of the novel sirolimus‐eluting bioresorbable scaffold for the treatment of de novo coronary artery disease: One‐year results from a prospective patient‐level pooled analysis of NeoVas trials

Published:2019-02-15 Issue:S1 Volume:93 Page:832-838
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Xu Kai¹,Fu Guosheng²,Xu Bo³,Zhou Yujie⁴,Su Xi⁵,Liu Huiliang⁶,Zhang Zheng⁷,Yu Bo⁸,Wang Xiaozeng¹,Han Yaling¹^ORCID,

Affiliation:

1. General Hospital of Northern Theater Command Shenyang Liaoning China

2. Department of Cardiology, Sir Run Run Shaw Hospital, College of MedicineZhejiang University, Hangzhou Zhejiang China

3. State Key Laboratory of Cardiovascular Disease, Department of Cardiology, Centre for Coronary Heart Disease, Fuwai Hospital, National Center for Cardiovascular DiseasesChinese Academy of Medical Sciences and Peking Union Medical College Beijing China

4. Department of Cardiology, Beijing Anzhen HospitalCapital Medical University Beijing China

5. Department of Cardiology, Wuhan Asia Heart HospitalAffiliated to Wuhan University of Science and Technology Wuhan Hubei China

6. Department of CardiologyChinese Armed Police Force General Hospital Beijing China

7. Department of CardiologyThe First Hospital of Lanzhou University Lanzhou Gansu China

8. Department of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, The Key Laboratory of Myocardial IschemiaChinese Ministry of Education Harbin China

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.28067

Reference38 articles.

1. Neoatherosclerosis: Overview of histopathologic findings and implications for intravascular imaging assessment;Otsuka F;Eur Heart J,2015

2. Drug‐eluting coronary‐artery stents;Stefanini GG;N Engl J Med,2013

3. 1‐Year outcomes of everolimus‐eluting bioresorbable scaffolds versus everolimus‐eluting stents: A propensity‐matched comparison of the GHOST‐EU and XIENCE V USA registries;Tamburino C;JACC Cardiovasc Interv,2016

4. The ABSORB bioresorbable vascular scaffold: A novel, fully resorbable drug‐eluting stent: Current concepts and overview of clinical evidence;Rizik DG;Catheter Cardiovasc Interv,2015

5. 2‐Year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: A systematic review and meta‐analysis of seven randomised trials with an individual patient data substudy;Ali ZA;Lancet,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term outcomes following bioresorbable vascular scaffolds;Expert Review of Cardiovascular Therapy;2024-07-30

2. Bioresorbable Scaffolds for Below-the-Knee Arterial Disease: A Literature Review of New Developments;Reviews in Cardiovascular Medicine;2024-04-03

3. Physicochemical Properties of the Ideal Materials for Cardiac Devices;Application of Biomaterials in the Treatment of Cardiovascular Diseases;2024

4. Dynamic changes in inflammatory responses and 3-year clinical outcomes of XINSORB scaffolds in coronary stenting;Cardiovascular Revascularization Medicine;2023-11

5. Mid-term safety and efficacy of magnesium bioresorbable vascular scaffolds – magmaris in diabetic population. 2-Years outcome in acute coronary syndrome cohort;Diabetes and Vascular Disease Research;2023-07